Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Colorcon
Argus Health
Deloitte
McKesson
McKinsey
Mallinckrodt
Cantor Fitzgerald

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075818

« Back to Dashboard

NDA 075818 describes FLUTAMIDE, which is a drug marketed by Actavis Labs Fl Inc, Cipla Ltd, Mylan, Par Pharm, and Yaopharma Co Ltd, and is included in five NDAs. It is available from four suppliers. Additional details are available on the FLUTAMIDE profile page.

The generic ingredient in FLUTAMIDE is flutamide. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flutamide profile page.
Summary for 075818
Tradename:FLUTAMIDE
Applicant:Yaopharma Co Ltd
Ingredient:flutamide
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 075818

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength125MG
Approval Date:Sep 18, 2001TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Citi
Argus Health
Cipla
Merck
US Department of Justice
Deloitte
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.